Trial Profile
A Dose-block Randomized, Single-blind, Placebo-controlled, Single-dosing, Dose-escalation Phase I Clinical Trial to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CJ-40002 After Subcutaneous Injection in Healthy Adult Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Somatotropin deficiency
- Focus Adverse reactions; Pharmacokinetics
- Sponsors CJ HealthCare; HK inno.N
- 04 Apr 2016 Status changed from not yet recruiting to completed according to results presented at The 98th Annual Meeting of the Endocrine Society.
- 17 Jun 2014 New trial record